Transcription profiling by array of lymphocytes from actue lymphoblastic leukemia patients immediately after total body irradation
Ontology highlight
ABSTRACT: To identify genes and related pathways that are regulated by radiotherapy in acute lymphoblastic leukemia (ALL) patients lymphocytes, we have employed whole genome microarray expression profiling as a discovery platform to identify genes associated with total body irradiation (TBI) therapy. Purified peripheral lymphocytes were sampled 24 h after each 4.5 Gray TBI treatment (total 9 Gray) from 4 adult patients receiving hematopoietic stem cell transplantation, and the results showed that 478 genes were differentially expressed with increasing TBI dose, and serial test of cluster (STC) analysis suggested three major patterns in these genes. Modulated genes were constructed to co-expression network and identified significant GO as follow: ubiquitin-dependent protein catabolic process, transcription, proteolysis and apoptosis et al. The reliability of the data obtained from the microarray was verified by performing quantitative real-time PCR on 12 representative genes. This study provides candidate genes associated with TBI sensitivity for further research.
Project description:Tissue damage precedes GvHD and the events leading up to this inflammatory disease are not well understood. To identify cell populations that may invade the intestinal tract after total body irradiation (TBI), we performed a microarray based gene expression analysis of the intestinal tract isolated from untreated mice or mice that had received 9 Gray TBI 24 h or 48 h previously. The aim of the microarray based gene expression analysis was to identify genes specific for certain cell populations that may contribute to GvHD.
Project description:X-ray CT was used to determine the growth velocity of individual tubers. RNA was extracted from tubers growing at different velocities and used for microarray hybridisation.
Project description:The experiment followed transcriptional changes during potato tuber induction from a stolon tip to a tuber. Samples were taken at stage 1, stage 3, stage 4 and stage 5 according to Kloosterman et al., 2005
Project description:Traumatic brain injury (TBI) causes hospitalizations and mortality worldwide with no approved neuroprotective treatments available, partly due to a poor understanding of the molecular mechanisms underlying TBI neuropathology and neuroprotection. We previously reported that the administration of low-dose methamphetamine (MA) induced significant functional/cognitive improvements following severe TBI in rats. We further demonstrated that MA mediates neuroprotection in part, via dopamine-dependent activation of the PI3K-AKT pathway. Here, we further investigated the proteomic changes within the rat cortex and hippocampus following mild TBI (TM), severe TBI (TS), or severe TBI plus MA treatment (TSm) compared to sham operated controls (n=78 in total). We quantified >7,000 unique proteins in total and identified 402 and 801 altered proteins (APs) with high confidence in cortical and hippocampal tissues, respectively. The overall profile of APs observed in TSm rats more closely resembled those seen in TM rather than TS rats. Pathway analysis suggested beneficial roles for acute signaling through IL-6, TGFβ, and IL-1β. Moreover, changes in fibrinogen levels observed in TSm rats suggested a potential role for these proteins in reducing/preventing TBI-induced coagulopathies. These data facilitate further investigations to identify specific pathways and proteins that may serve as key targets for the development of neuroprotective therapies.
Project description:U-2 OS (human osteosarcoma cell line) were treated with ZM447439 (an aurora kinase inhibitor), SB202190 (a p38 inhibitor) or ZM447439+SB202190 and resulting changes in gene expression were profiled.
Project description:Transcriptional profiling of e8.5 mouse embryos comparing wt with Srd5a3Gt(betaGeo)703Lex/Gt(betaGeo)703Lex. Goal was to determine the developmental pathway disrupted in the mutant.<br>
Project description:Microarray analyses of WPMY-1 <br><br>cells, either untreated (solvent) or treated with <br><br>GW501516 (0.3 µM), TGFBeta2 (10 ng/ml), or <br><br>both ligands for 6 h.
Project description:Total RNAs were extracted from the hippocampus and prefrontal cortex of anxious mice. The transcriptome of the two brain regions were investigated using a custom made Agilent 8 x 15k features oligo microarray.